A Study to Investigate the Safety, Tolerability, Pharmacokinetics of ALZ002 DS in Healthy Volunteers
Clinical trial NCT04392830 · COMPLETED
Trial details
- NCT number
- NCT04392830
- Sponsor
- AnnJi Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-11
- Primary completion
- 2021-04-28
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.